DanielFHoftMD

Infectious Disease • Saint Louis, MO

Microbiology

Physician

Join to view full profile

Dr. Hoft is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hoft's full profile

Already have an account?

Office
3660 Vista Ave
Saint Louis, MO 63110
Phone+1 314-577-8648

Fax+1 314-771-3816

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Infectious Disease, 1989 - 1992
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1985 - 1989
University of Missouri-Columbia School of MedicineClass of 1985

Certifications & Licensure

MO State Medical License 1992 - 2025
IA State Medical License 1985 - 1993
American Board of Internal Medicine Internal Medicine

Clinical Trials

Study of AERAS 422 in Healthy Adults Start of enrollment: 2010 Dec 01
Completed
Phase 1
Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years Start of enrollment: 2011 Feb 24
Completed
Phase 4
H3N2 M2SR in Pediatric Population Start of enrollment: 2018 Aug 15
Completed
Phase 1

Publications & Presentations

PubMed

Intranasal M2SR (M2-deficient Single Replication) Influenza Vaccine Induces Broadly Reactive Mucosal Antibody Production in Adults.
Lindsay Hill-Batorski, Joshua A Weiner, Margaret E Ackerman, Yasuko Hatta, Daniel F Hoft
The Journal of Infectious Diseases. 2024-07-16
1 citations
Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination.
Richard F Silver, Mei Xia, Chad E Storer, Jessica R Jarvela, Michelle C Moyer
Nature Communications. 2023-12-21
1 citations
Lower risk for COVID-19 hospitalization among patients in the United States with past vaccinations for herpes zoster and tetanus, diphtheria and pertussis.
Joanne Salas, John E Morley, Daniel F Hoft, Jeffrey F Scherrer
Preventive Medicine Reports. 2023-10-01

Press Mentions

SLU Researchers Begin Enrolling Adolescents in Mpox Vaccine Clinical TrialApril 5th, 2023
Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported StudyMarch 6th, 2023
Founder of SLU’s Vaccine Center Receives Lifetime Honor for Career Spent Fighting Infectious DiseasesFebruary 16th, 2023
Join now to see all